
Customer Care Associate (French Speaking) | Oxford Nanopore Technologies
Location: Oxford
Working Model: Hybrid
About Us:
At Oxford Nanopore Technologies, we’re enabling the analysis of anything, by anyone, anywhere. Our pioneering nanopore sequencing technology is transforming the way scientists and clinicians understand biology, and delivering an exceptional customer experience is critical to supporting that mission.
We’re looking for an French-speaking Customer Care Associate to join our Customer Care team, playing a key role in supporting our French-speaking customer base as well as internal stakeholders. This is an exciting opportunity to be part of a fast-growing, purpose-driven organization where your contribution directly supports world-leading science.
About the Role
Customer Care Associates provide outstanding customer service by handling inbound/outbound routine customer inquiries and ensuring a positive experience for both external and internal customers. This role is responsible and accountable for supporting customers and solving any issues using ONT specific communication channels, performing standardized work routines with close supervision, and collaborating with the team to contribute to departmental goals.
Reporting to the Associate Director, this role requires a proactive, customer-first mindset and a ‘ goes above and beyond’ attitude to support customers proactively and swift manner.
Key Responsibilities
What We’re Looking For
Why Join Oxford Nanopore?
You’ll be part of a collaborative and innovative environment where your work directly supports customers advancing scientific discovery and healthcare globally. This role is ideal for someone who enjoys making an impact, takes ownership, and is motivated to go the extra mile for both customers and colleagues.
If you’re a French-speaking customer care professional excited by the opportunity to support world-changing science, we’d love to hear from you.
Please note that no terminology in this advert is intended to discriminate on the grounds of a person's gender, marital status, race, religion, colour, age, disability or sexual orientation. Every candidate will be assessed only in accordance with their merits, qualifications and abilities to perform the duties of the job.
#LI-LH1
#LI-hybrid
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.

Our goal is to enable the analysis of anything, anywhere, by anyone.
We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data.
We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society.
Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide.
Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.